Antiarrhythmic class drugs

26 results
  • amiodarone hydrochloride

    (Amiodarone Hydrochloride)
    Advagen Pharma Limited
    Amiodarone Hydrochloride Tablets are indicated for treating documented, life-threatening recurrent ventricular fibrillation and unstable tachycardia in adults who have not adequately responded to other antiarrhythmics or cannot tolerate alternative treatments.
  • amiodarone hydrochloride

    (Amiodarone Hydrochloride)
    Chartwell RX, LLC
    Amiodarone hydrochloride is indicated for treating documented life-threatening recurrent ventricular fibrillation and hemodynamically unstable tachycardia in adults unresponsive to other antiarrhythmics or when alternative medications are intolerable.
  • amiodarone hydrochloride

    (amiodarone hydrochloride)
    Zhejiang Poly Pharm. Co., Ltd.
    Amiodarone injection is indicated for the initiation of treatment and prevention of recurrent ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients unresponsive to other therapies. It can also be used for patients needing oral therapy but unable to take oral medication, facilitating a transition to oral amiodarone.
  • dofetilide 0.125mg

    (Dofetilide 0.125mg)
    Granules Pharmaceuticals Inc.
    Dofetilide is indicated for maintaining normal sinus rhythm in patients with atrial fibrillation/atrial flutter who have been converted from AF/AFl and for conversion of AF/AFl to normal sinus rhythm. It is reserved for symptomatic patients due to potential life-threatening ventricular arrhythmias.
  • flecainide acetate

    (flecainide acetate)
    Epic Pharma, LLC
    Flecainide Acetate Tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for documented life-threatening sustained ventricular tachycardia. Caution is advised due to proarrhythmic effects, and they should not be used post-myocardial infarction.
  • flecainide acetate

    (flecainide acetate)
    Bayshore Pharmaceuticals LLC
    Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for life-threatening documented ventricular arrhythmias, but should not be used post-myocardial infarction or for less severe arrhythmias. Consideration of risks is essential.
  • lidocaine and prilocaine

    (Lidocaine and Prilocaine)
    PAI Holdings, LLC dba PAI Pharma
    Lidocaine and Prilocaine Cream 2.5%/2.5% is indicated as a topical anesthetic for local analgesia on normal intact skin and for superficial procedures on genital mucous membranes. It is not recommended for use where penetration beyond the tympanic membrane may occur due to potential ototoxic effects.